# Labetalol

## Trandate inj 25mg/5mL

| TAH Drug Code      | [ITRAD](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ITRAD)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Indicated for the rapid emergency control of severe hypertension， including severe pregnancy-induced hypertension， and for blood pressure reduction during anesthesia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Dosing             | IV bolus: Given 50 mg over 1 minute and may repeat every 5 minutes until desired blood pressure is achieved or up to a total maximum of 200 mg. IV infusion: Diluted with saline or 5% Dextrose solution to 1 mg/mL， administered 2 mg/minute initially. Gestational hypertension: Initial， 20mg/hour as an IV infusion， then double the dose in every 30 minutes until desired blood pressure is achieved or up to 160mg/hours. May give higher dosage when necessary. Blood pressure management in acute myocardial infarction: Initially give 15 mg/hour via infusion then increase gradually to maximum 120 mg/hour adjusted by blood pressure. Hypertension due to other causes: Initially give 2 mg/minute via infusion then adjust infusion rate to blood pressure response. The effective dose usually around 50-200 mg. Higher dosage may be required in particular patients， especially with pheochromocytoma. The infusion rate can be adjusted by the doctor according to the reaction. Blood pressure management in operative procedure: Initially IV 10-20 mg， add supplemental dose 5-10 mg every 5 minutes until target blood pressure is reached. (use with halothane) Patients with contraindications for halothane usually need the higher initial dose (25-30 mg). |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Non-selective β-blockers are contraindicated in patients with asthma or a history of obstructive airway disease. Trandate Injection is contraindicated in: Second- or third-degree heart block (unless a pacemaker is present) Cardiogenic shock Severe， persistent hypotension or severe bradycardia Trandate Injection is contraindicated in patients with known hypersensitivity to the active ingredient or excipients.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | Pronounced postural hypotension， nasal congestion. Rarely hypersensitivity， rash， pruritus， angioedema & dyspnea; raised liver function tests， jaundice， hepatitis & hepatitis necrosis; bradycardia， heart block. Cardiovascular: Orthostatic hypotension (1%， oral ; 58%， IV ) Dermatologic: Has tingling sensation (7% .) Gastrointestinal: Nausea (14% ) Neurologic: Dizziness (9% to 20% ) Respiratory: Nasal congestion (3% ) Other: Fatigue (11% )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/labetalol-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

## Labtal 200mg

| TAH Drug Code      | [OLAB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OLAB)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypertension.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Dosing             | Hypertension: Initially 100 mg BID. May increase in increments of 100 mg twice daily intermittently every 2-14 days. Usual maintenance: 200mg BID. Maximum: 800 mg/day in 2 divided doses. Patients with severe hypertension may require 2400 mg/day， in 3-4 divided doses. Older Adult， Initial: 50 mg twice daily and consider lower maintenance doses. Gestational hypertension: Initially 100 mg BID. May increase in increments of 100 mg twice daily intermittently in the 1-week intervals. The total daily dose may be divided into 3 divided doses for patients with severe hypertension. Maximum: 2400mg/day. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Bronchial asthma Obstructive airway disease Cardiogenic shock Decompensated heart failure Greater than first degree heart block Severe bradycardia Non-dihydropyridine calcium-channel antagonist Hypersensitivity reactions， including anaphylaxis， to labetalol                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | Common Gastrointestinal: Nausea (Oral， 6%) Neurologic: Dizziness (Oral， 11%) Other: Fatigue (Oral， 5% ) Serious Cardiovascular: Decreased cardiac output， Heart failure， Hypertension， Paradoxical， Myocardial ischemia， Orthostatic hypotension (Oral， 1% ; IV， 58% ) Hepatic: Hepatocellular liver damage， Jaundice Immunologic: Anaphylaxis Ophthalmic: Intraoperative floppy iris syndrome                                                                                                                                                                                                                 |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/labetalol-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

